ORGO
Income statement / Annual
Last year (2023), Organogenesis Holdings Inc.'s total revenue was $433.14 M,
a decrease of 3.94% from the previous year.
In 2023, Organogenesis Holdings Inc.'s net income was $4.95 M.
See Organogenesis Holdings Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$433.14 M
|
$450.89 M
|
$468.06 M
|
$338.30 M
|
$260.98 M
|
$193.45 M
|
$0.00
|
$0.00
|
| Cost of Revenue |
$123.35 M |
$105.02 M |
$114.20 M |
$87.32 M |
$75.95 M |
$68.81 M |
$4.59 M |
$208,698.00 |
| Gross Profit |
$309.79 M |
$345.87 M |
$353.86 M |
$250.98 M |
$185.03 M |
$124.64 M |
-$4.59 M |
-$208,698.00 |
| Gross Profit Ratio |
0.72 |
0.77 |
0.76 |
0.74 |
0.71 |
0.64 |
0 |
0 |
| Research and Development
Expenses |
$44.38 M
|
$39.76 M
|
$30.74 M
|
$20.09 M
|
$14.80 M
|
$10.74 M
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$264.53 M
|
$279.00 M
|
$244.68 M
|
$200.76 M
|
$198.63 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$5.23 M
|
$4.81 M
|
$5.52 M
|
$2.72 M
|
$1.06 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$269.75 M
|
$283.81 M
|
$250.20 M
|
$203.48 M
|
$199.69 M
|
$161.96 M
|
$4.59 M
|
$208,698.00
|
| Other Expenses |
$0.00 |
-$13,000.00 |
-$13,000.00 |
$97,000.00 |
$13,000.00 |
$162,000.00 |
$0.00 |
$208,698.00 |
| Operating Expenses |
$314.13 M |
$323.57 M |
$280.94 M |
$223.56 M |
$214.49 M |
$172.70 M |
$4.59 M |
$208,698.00 |
| Cost And Expenses |
$420.62 M |
$428.59 M |
$395.14 M |
$310.88 M |
$290.44 M |
$241.51 M |
$4.59 M |
$208,698.00 |
| Interest Income |
$0.00 |
$2.01 M |
$7.24 M |
$11.28 M |
$9.00 M |
$64,000.00 |
$2.50 M |
$153,000.00 |
| Interest Expense |
$2.19 M |
$2.01 M |
$7.24 M |
$11.28 M |
$9.00 M |
$10.85 M |
$8.01 M |
$5.63 M |
| Depreciation &
Amortization |
$23.45 M
|
$18.03 M
|
$16.68 M
|
$8.18 M
|
$9.43 M
|
$6.98 M
|
$5.63 M
|
-$417,396.00
|
| EBITDA |
$36.03 M
|
$40.32 M
|
$87.00 M
|
$37.23 M
|
-$21.88 M
|
-$46.92 M
|
-$2.09 M
|
-$1.76 M
|
| EBITDA Ratio |
0.08 |
0.09 |
0.19 |
0.1 |
-0.08 |
-0.21 |
0 |
0 |
| Operating Income Ratio
|
0.03
|
0.05
|
0.16
|
0.08
|
-0.11
|
-0.27
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$2.13 M
|
-$2.02 M
|
-$9.13 M
|
-$8.94 M
|
-$10.85 M
|
-$13.19 M
|
$3.40 M
|
$8.57 M
|
| Income Before Tax |
$10.39 M |
$20.28 M |
$63.79 M |
$18.48 M |
-$40.30 M |
-$64.75 M |
-$2.09 M |
-$208,698.00 |
| Income Before Tax Ratio
|
0.02
|
0.04
|
0.14
|
0.05
|
-0.15
|
-0.33
|
0
|
0
|
| Income Tax Expense |
$5.45 M |
$4.75 M |
-$31.12 M |
$530,000.00 |
$150,000.00 |
$84,000.00 |
-$52,516.00 |
-$440,212.00 |
| Net Income |
$4.95 M |
$15.53 M |
$94.20 M |
$17.23 M |
-$40.45 M |
-$64.83 M |
-$2.09 M |
-$208,698.00 |
| Net Income Ratio |
0.01 |
0.03 |
0.2 |
0.05 |
-0.16 |
-0.34 |
0 |
0 |
| EPS |
0.0377 |
0.12 |
0.73 |
0.16 |
-0.44 |
-0.94 |
-0.0328 |
-0.0033 |
| EPS Diluted |
0.0373 |
0.12 |
0.7 |
0.15 |
-0.44 |
-0.94 |
-0.0328 |
-0.0033 |
| Weighted Average Shares
Out |
$131.23 M
|
$130.07 M
|
$128.33 M
|
$107.74 M
|
$92.84 M
|
$68.97 M
|
$63.88 M
|
$63.20 M
|
| Weighted Average Shares
Out Diluted |
$132.75 M
|
$132.38 M
|
$133.66 M
|
$111.36 M
|
$92.84 M
|
$69.32 M
|
$63.88 M
|
$63.20 M
|
| Link |
|
|
|
|
|
|
|
|
